Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy

G Sharma, K Wadhwa, S Kumar, G Singh… - Drug Delivery and …, 2025 - Springer
Parkinson's disease (PD) is the most prominent and highly prevalent chronic neuro-
degenerative disease generally recognized by classical motor symptoms which are linked …

Molecular determinants for brain targeting by peptides: a meta-analysis approach with experimental validation

M Cavaco, P Fraga, J Valle, RDM Silva, L Gano… - Fluids and Barriers of …, 2024 - Springer
Blood–brain barrier (BBB) peptide-shuttles (BBBpS) are able to translocate the BBB and
reach the brain. Despite the importance of brain targeting in pharmacology, BBBpS are …